AD (n = 16,494) | Matched Cohort (No AD or Dementia) (n = 49,482) | P value* | |||
---|---|---|---|---|---|
Mean [SD] | Median | Mean [SD] | Median | ||
Deyo Charlson Comorbidity Index | 3.8 [3.0] | 3.0 | 3.0 [2.9] | 2.0 | < 0.001 |
RxRisk-V Score | 9.8 [4.0] | 10.0 | 8.3 [3.7] | 8.0 | < 0.001 |
Number of Unique Medications Used (Drug Classes) | 22.0 [14.0] | 20.0 | 18.2[10.7] | 17.0 | |
Wellness Visit and Assessments, n (%) | |||||
Annual Medicare Wellness Visit | 4832 (29.5) | 17,132 (35.0) | < 0.001 | ||
Cognitive Assessment | 435 (2.6) | 114 (0.2) | < 0.001 | ||
AD medication use at baseline | 10,559 (64.0) | 884 (1.8) |